Φορτώνει......
Statin use and pancreatic cancer risk in two prospective cohort studies
BACKGROUND: Statins, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are common lipid-lowering agents and may reduce the risk of several cancer types including pancreatic cancer. However, the association between statin use and pancreatic cancer risk has not been fully evaluated...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7609961/ https://ncbi.nlm.nih.gov/pubmed/29362938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-018-1430-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|